Transformation system for Camelina sativa

Abstract

In order to better aid consumers of prescription medicine and the like in efficient and rapid identification of the correct pill to be taken from among multiple containers, a novel group of articles of manufacture adapted for use with end-use prescription medicine containers at least includes a plurality of predetermined medicine purpose types corresponding to different types of medical or vitality purposes that underlying medicines are targeted to treat or address. Each article of manufacture is adapted to be coupled to an end-use, target prescription medicine container by an end-user or pharmacy function, and each article of manufacture at least includes an ideogram adapted to encourage a psychological association with, and identification of, the medicine expected to be placed in the target prescription medicine container to which the article of manufacture is adapted, and each article of manufacture is associated with a particular medicine purpose type.

1 . A transgenic plant characterized in that it comprises a  Camelina sativa  plant obtainable by a method comprising the steps of:
 a) Providing sterilized  Camelina sativa  material collected from a plants grown in controlled conditions;   b) Culturing the material on agar in sterilized conditions and growing in vitro seedlings;   c) Obtaining explants from the in vitro grown seedlings;   d) Inoculating the explants with  Agrobacterium tumefaciens  strain containing at least one recombinant DNA construct;   e) Cocultivating the explant with the  Agrobacterium  strain;   f) Transferring the explants to a callus forming medium, said medium being supplemented with hormones and containing 2% sucrose;   g) Transferring the explants to a shoot regeneration medium, said medium being supplemented with hormones and containing 2-6% sucrose;   h) Transferring the shoots to a root elongation medium, said medium being supplemented with hormones and containing 1-4%; and,   i) Transferring the regenerated shoots into soil and growing them to transgenic  Camelina sativa  plants.   
     
     
         2 . A transgenic plant tissue characterized in that it comprises a  Camelina sativa  tissue obtainable by the method of  claim 1 . 
     
     
         3 . A transgenic plant cell or cell lines characterized in that it comprises a  Camelina sativa  cell or cell lines obtainable by the method of  claim 1 . 
     
     
         4 . Transgenic seed characterized in that it comprises a  Camelina sativa  seed obtainable by the method of  claim 1 .